Lee et al., 2013 - Google Patents
Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stressLee et al., 2013
View PDF- Document ID
- 7571116827155913959
- Author
- Lee J
- Koh K
- Kim Y
- Ahn J
- Kim S
- Publication year
- Publication venue
- Journal of General Virology
External Links
Snippet
NF-E2 related factor 2 (Nrf2) is a transcription factor that plays a key role (s) in cellular defence against oxidative stress. In this study, we showed that the expression of Nrf2 was upregulated in primary human foreskin fibroblasts (HFFs), following human cytomegalovirus …
- 102100017234 NFE2L2 0 title abstract description 146
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/10011—Adenoviridae
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress | |
| Lahaye et al. | Hsp70 protein positively regulates rabies virus infection | |
| Matskevich et al. | Dicer is involved in protection against influenza A virus infection | |
| Kim et al. | SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication | |
| Kumar et al. | NF-κB signaling differentially regulates influenza virus RNA synthesis | |
| Pan et al. | Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection | |
| Li et al. | Transcriptional derepression of the ERVWE1 locus following influenza A virus infection | |
| Stepp et al. | Sp100 provides intrinsic immunity against human papillomavirus infection | |
| Xie et al. | Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment | |
| Mlcochova et al. | DNA damage induced by topoisomerase inhibitors activates SAMHD 1 and blocks HIV‐1 infection of macrophages | |
| Li et al. | Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis | |
| Clerzius et al. | The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication | |
| Qian et al. | Murine cytomegalovirus targets transcription factor ATF4 to exploit the unfolded-protein response | |
| Chen et al. | Promyelocytic leukemia restricts enterovirus 71 replication by inhibiting autophagy | |
| Biswas et al. | ADAR1 is a novel multi targeted anti-HIV-1 cellular protein | |
| Matthews et al. | Analysis of subcellular G3BP redistribution during rubella virus infection | |
| Wang et al. | Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis | |
| Lange et al. | Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing | |
| Cao et al. | Suppression of poxvirus replication by resveratrol | |
| Dinh et al. | Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression | |
| Patzina et al. | Human interactome of the influenza B virus NS1 protein | |
| Ramalingam et al. | Viral microRNAs target a gene network, inhibit STAT activation, and suppress interferon responses | |
| Fu et al. | Lentivirus-mediated Bos taurus bta-miR-29b overexpression interferes with bovine viral diarrhoea virus replication and viral infection-related autophagy by directly targeting ATG14 and ATG9A in Madin–Darby bovine kidney cells | |
| Hao et al. | Dissecting the role of DDX21 in regulating human cytomegalovirus replication | |
| Lee et al. | A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL/6 mice |